Raphas Co., Ltd. (KOSDAQ:214260)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,980.00
+160.00 (1.63%)
At close: Apr 1, 2026
Market Cap82.57B -37.9%
Revenue (ttm)30.99B +13.3%
Net Income-4.31B
EPS-484.00
Shares Out8.41M
PE Ratio129.88
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume36,606
Average Volume28,014
Open9,920.00
Previous Close9,820.00
Day's Range9,740.00 - 10,070.00
52-Week Range9,120.00 - 21,500.00
Beta0.90
RSI42.07
Earnings DateMar 30, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea. [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2006
Employees 79
Stock Exchange KOSDAQ
Ticker Symbol 214260
Full Company Profile

Financial Performance

In 2025, Raphas's revenue was 30.99 billion, an increase of 13.86% compared to the previous year's 27.22 billion. Losses were -4.31 billion, -9.58% less than in 2024.

Financial Statements